Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.

MLA

Rabal, Obdulia, et al. “Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.” Journal of Medicinal Chemistry, vol. 64, no. 6, Mar. 2021, pp. 3392–426. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.0c02255.

APA

Rabal, O., San José-Enériz, E., Agirre, X., Sánchez-Arias, J. A., de Miguel, I., Ordoñez, R., Garate, L., Miranda, E., Sáez, E., Vilas-Zornoza, A., Pineda-Lucena, A., Estella, A., Zhang, F., Wu, W., Xu, M., Prosper, F., & Oyarzabal, J. (2021). Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma. Journal of Medicinal Chemistry, 64(6), 3392–3426. https://doi.org/10.1021/acs.jmedchem.0c02255

Chicago

Rabal, Obdulia, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Irene de Miguel, Raquel Ordoñez, Leire Garate, et al. 2021. “Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.” Journal of Medicinal Chemistry 64 (6): 3392–3426. doi:10.1021/acs.jmedchem.0c02255.